A clinical prediction rule for lymphoma development in primary Sjögren's syndrome

Journal of Rheumatology

Volumn 39, Issue 4, 2012, Pages 804-808

  Baldini, Chiara ^a   Pepe, Pasquale ^a   Luciano, Nicoletta ^a   Ferro, Francesco ^a   Talarico, Rosaria ^a   Grossi, Sara ^a   Tavoni, Antonio ^a   Bombardieri, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Non Hodgkin's lymphoma; Prediction model; Prognosis; Sj gren's syndrome

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE SULFATE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RISK; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PAROTIDECTOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; RISK FACTOR; SALIVARY GLAND DISEASE; SENSITIVITY AND SPECIFICITY; SEROLOGY; SJOEGREN SYNDROME; VALIDATION PROCESS;

AGED; COHORT STUDIES; COMORBIDITY; DISEASE PROGRESSION; FEMALE; FORECASTING; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 84859465132     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110754     Document Type: Article

References (26)

1. Mavragani CP, Moutsopoulos HM. The geoepidemiology of Sjögren's syndrome. Autoimmun Rev 2010;9:A305-10.
2. Voulgarelis M, Skopouli FN. Clinical, immunologic, and molecular factors predicting lymphoma development in Sjögren's syndrome patients. Clin Rev Allergy Immunol 2007;32:265-74. (Pubitemid 350242572)
3. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: A meta-analysis. Arch Intern Med 2005;165:2337-44. (Pubitemid 41640845)
4. Pillemer SR. Lymphoma and other malignancies in primary Sjögren's syndrome. Ann Rheum Dis 2006;65:704-6. (Pubitemid 43799166)
5. Mariette X. Lymphomas in patients with Sjögren's syndrome: Review of the literature and physiopathologic hypothesis. Leuk Lymphoma 1999;33:93-9. (Pubitemid 29116398)
6. Voulgarelis M, Moutsopoulos HM. Malignant lymphoma in primary Sjögren's syndrome. Isr Med Assoc J 2001;3:761-6. (Pubitemid 34082747)
7. Fietta P, Delsante G, Quaini F. Hematologic manifestations of connective autoimmune diseases. Clin Exp Rheumatol 2009;27:140-54.
8. Voulgarelis M, Moutsopoulos HM. Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: Risks, management, and prognosis. Rheum Dis Clin North Am 2008;34:921-33, viii.
9. Voulgarelis M, Tzioufas AG, Moutsopoulos HM. Mortality in Sjögren's syndrome. Clin Exp Rheumatol 2008;5 Suppl 51:S66-71.
10. Sutcliffe N, Inanc M, Speight P, Isenberg D. Predictors of lymphoma development in primary Sjögren's syndrome. Semin Arthritis Rheum 1998;28:80-7. (Pubitemid 28480892)
11. Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjögren's syndrome: A multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum 1999;42:1765-72. (Pubitemid 30263648)
12. Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum 2000;29:296-304. (Pubitemid 30235981)
13. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002;46:741-7. (Pubitemid 34214255)
14. Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LTH. Lymphoma and other malignancies in primary Sjögren's syndrome: A cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006;65:796-803. (Pubitemid 43799181)
15. Brito-Zerón P, Ramos-Casals M, Bove A, Sentis J, Font J. Predicting adverse outcomes in primary Sjögren's syndrome: identification of prognostic factors. Rheumatology 2007;46:1359-62. (Pubitemid 47244514)
16. Wittoek R, De Keyser F, Boonen A, De Vlam K, Vastesaeger N, Mielants H, et al. Classification models for disease: The effect of associations between markers on calculating the risk for disease by likelihood ratio products. Clin Exp Rheumatol 2009;27:272-6.
17. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8. (Pubitemid 34539104)
18. Seror R, Mariette X, Bowman S, Baron G, Gottenberg JE, Boostma H, et al European League Against Rheumatism Sjögren's Task Force. Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index. Arthritis Care Res 2010;62:551-8.
19. Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, et al EULAR Sjögren's Task Force. EULAR Sjögren's syndrome disease activity index: Development of a consensus systemic disease activity index for primary Sjögren's syndrome. Ann Rheum Dis 2010;69:1103-9.
20. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 2000;36:69-86.
21. The R Project for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria; 2005. [Internet. Accessed December 13, 2011.] Available from: http://www.R-project.org
22. Stevenson M, Nunes T, Sanchez J, Thornton R. epiR: Functions for analysing epidemiological data. R package version 0.9-27. 2010. [Internet. Accessed December 13, 2011.] Available from: http://CRAN.R-project.org/package= epiR
23. Henderson AR. The bootstrap: a technique for data-driven statistics using computer-intensive analyses to explore experimental data. Clin Chim Acta 2005;359:1-26. (Pubitemid 41116294)
24. Carpenter J. Bootstrap methods and their application. Davison AC, Hinkley DV, editors. Cambridge: Cambridge University Press; 1997. Epidemiol infection 1998;121:485.
25. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7. (Pubitemid 23090601)
26. Ramos-Casals M, Brito-Zerón P, Yagüe J, Akasbi M, Bautista R, Ruano M, et al. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjögren's syndrome. Rheumatology 2005;44:89-94. (Pubitemid 40124338)